Canada can be a leader in delivering widespread, well-regulated psychedelic-assisted therapy for people with depression, anxiety, post-traumatic stress disorder and substance abuse, by investing in research, educating health care professionals and providing the necessary clinical infrastructure, Dr. Ross Marshall, chief scientific officer at The Newly Institute based in Calgary, says in an op-ed.
Organization: Health Canada
The Short Report – June 28, 2022: Anand’s NORAD upgrade plans for space-based surveillance system; new funding streams strengthen Canada’s clinical trials; CIFAR launches Phase 2 of the Pan-Canadian Artificial Intelligence Strategy, and more.
NORAD upgrades include plans for a space-based surveillance system and a science program with the US; three new funding streams to bolster Canada’s clinical trials, phase 2 of the Pan-Canadian Artificial Intelligence Strategy launches, and more.
Debating decrim: hard drugs and hard decisions
Researchers are touting B.C.’s pilot initiative to decriminalize hard drug possession as a model to be applied across the country. They suggest studies to determine the efficacy of this approach to managing the harmful effect of addiction.
The Short Report – June 1, 2022: IBM boosts research and innovation at Memorial U; formalizing a framework for AI and data science research, Ottawa supports a national energy modelling hub, and more.
IBM invests to strengthen research and innovation in Newfoundland and Labrador; a framework to deepen links between the NRC and Canada’s AI research and industry ecosystem, an energy hub to connect modellers and policymakers, and more.
The Short Report – May 4, 2022: An international AI lab kicks off in Montreal, a call for proposals for Ottawa’s new IP program, Alberta’s new hydrogen centre of excellence, and more.
A consortium of AI-focused research organizations launches in Montreal; François-Philippe Champagne opens call for proposals for the $90-million ElevateIP program announced in Budget 2021; Alberta commits $50 million towards clean hydrogen technology research, and more.
Alberta and federal governments co-invest $900,000 to grow province’s hemp industry
The Alberta government is providing a total of $900,000 in grants to two hemp companies, INCA Renewable Technologies and Blue Sky Hemp Ventures, to help grow the hemp industry in the province.
SSHRC shares progress on implementing Indigenous Strategic Research Plan following pandemic setbacks
The Social Sciences and Humanities Research Council has made some progress in implementing the two-year old federal Indigenous Strategic Research Plan, although Indigenous stakeholders caution it could take generations to fully implement the plan and see the impact on reconciliation.
New clinical approaches, research and funding needed to treat early traumas driving mental illness
More investment and research is needed to effectively treat the traumas that underlie mental illness and enable people to quickly get back to work and back to life, Dr. Robert Tanguay, vice-president and chief medical officer at The Newly Institute based in Calgary, says in an op-ed.
As Canada eases restrictions on psychedelics, B.C.-based Numinus prepares for clinical trials
Numinus has received Health Canada approval to conduct a clinical trial to test the effects of MDMA, the amphetamine more commonly known as ecstasy, in the treatment of patients suffering from severe post-traumatic stress disorder.
The Short Report – Feb. 16, 2022: Congruence Therapeutics raises $63M for rare disease drug discovery, a multi-billion dollar Euro tech fund, a Conservative cryptoasset bill, and more
Biotech entrepreneur Clarissa Desjardins secures funding to develop drugs for rare diseases, the EU creates a multi-billion dollar fund to reduce dependence on foreign tech giants, CPC MP Michelle Rempel Garner tables a private member bill to attract investment in cryptoassets, and more.